TROG_2014_ASM-program

TROG 201426th ANNUAL SCIENTIFIC MEETING 18TROG 201419 26th ANNUAL SCIENTIFIC MEETING12.45 - 1.05pm New Proposals: Category A Research Projects Chair:F Foroudi12.45pm12.55pm1.05 - 2.00pm LunchRADAR Sub-Study: Survivorship sub-study of theRADAR trialRANZAR: Registry of Australian and New ZealandAblative RadiotherapyJ DenhamJ Ruben1.05 - 1.30pm TROG 08.06 (STARS) Trial Management Committee P Graham1.05 - 1.50pm SPARK: Stereotactic Prostate Adaptive Radiotherapyutilising KIM (Kilovoltage Intrafraction Monitoring)P Keall1.30 - 2.00pm TROG 03.01 Trial Management Committee M Penniment1.15 - 2.00pm TROG New Technologies and Techniques Committee T Kron1.30 - 2.00pm TROG 05.01 (POST) Trial Management Committee S Porceddu1.30 - 2.00pm TROG 07.01 (DCIS) Trial Management Committee B Chua2.00 - 2.40pm Bladder Chair:D Christie2.00pm2.10pm2.20pm2.30pm10.01 (BOLART): Multi-Centre Feasibility study ofOnline Adaptive Image Guided Radiotherapy for MuscleInvasive Bladder Cancer (Closed)02.03: Multicentre Phase III study comparing radicalsynchronous chemo-radiation vs radical radiationalone in the definitive management of muscle invasiveof the urinary bladder following maximal TUR(Closed)RAIDER-B: A randomised phase III trial of adaptiveimage guided standard or dose escalated radiotherapyin the treatment of transitional cell carcinoma of thebladder (Approved for Development)BOB-RT: Better Outcomes for Palliative Radiotherapy ofBladder Cancer (Approved for Development)F ForoudiK GognaF ForoudiA Capp2.40 - 3.00pm Symptom Management Chair:D Christie2.40pm03.08 (NCIC SC.20): A phase III internationalrandomised trial of single versus multiple fractionsfor re-irradiation of painful bone metastases (Closed)D Roos3.00 - 3.20pm Innovations in Research Chair:D Christie3.00pm Innovations in TROG QA J Hatton3.10pmimagine3.20- 3.40pm Afternoon TeaTranslational Research in the context of a Co-operativeClinical Trial OrganisationH Elsaleh3.40 - 5.00pm Annual General Meeting Chair:S Porceddu7.00 - 11.00pm Gala Dinner sponsored by BrainLab...advanced technology withthe patient in mindWith Elekta, it’s reality.Every day, more than 100,000 patients worldwide are diagnosed, treated orreceive follow-up with the help of an oncology or neurosurgery solution fromElekta. Through innovation and collaboration, we are advancing patient care.Human care makes the future possibleMore at elekta.com.auNeuroscienceTreatment Planning& Information SoftwareOncologyBrachytherapy